⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18780288 | 0.95 | — | — | |
| SCHEMBL24446090 | 0.79 | — | — | |
| SCHEMBL20257778 | 0.78 | — | — | |
| SCHEMBL11784440 | 0.77 | — | — | |
| SCHEMBL24200855 | 0.76 | — | — | |
| SCHEMBL22546613 | 0.72 | — | — | |
| SCHEMBL24244882 | 0.72 | — | — | |
| SCHEMBL11760890 | 0.71 | — | — | |
| SCHEMBL29889 | 0.71 | — | — | |
| SCHEMBL26706040 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4306614-A1 | LIQUID-CRYSTALLINE MEDIUM | Merck Patent GmbH (DE) | 2024-01-17 | — | — | EP | disclosed |
| US-20230340328-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2023-10-26 | — | — | US | disclosed |
| US-20230312786-A1 | PRODUCTION METHOD FOR CYCLIC OLEFIN COPOLYMER | POLYPLASTICS CO., LTD. (JP) | 2023-10-05 | — | — | US | disclosed |
| EP-4249570-A1 | LIQUID-CRYSTALLINE MEDIUM | Merck Patent GmbH (DE) | 2023-09-27 | — | — | EP | disclosed |
| US-20230183571-A1 | LIQUID-CRYSTAL MEDIUM COMPRISING POLYMERIZABLE COMPOUNDS | MERCK PATENT GMBH (DE) | 2023-06-15 | — | — | US | disclosed |
| EP-4194529-A1 | LIQUID-CRYSTAL MEDIUM COMPRISING POLYMERIZABLE COMPOUNDS | Merck Patent GmbH (DE) | 2023-06-14 | — | — | EP | disclosed |
| EP-3892706-A2 | LIQUID-CRYSTALLINE MEDIUM | Merck Patent GmbH (DE) | 2021-10-13 | — | — | EP | disclosed |